高级检索
当前位置: 首页 > 详情页

Single nucleotide polymorphisms in the mitochondrial displacement loop region and outcome of malignant fibrous histiocytoma

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Osteology,The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China [2]Department of Clinical Laboratory,The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China [3]Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China
出处:
ISSN:

关键词: D-loop malignant fibrous histiocytoma mtDNA outcome SNP

摘要:
Purpose: Single nucleotide polymorphisms (SNPs) in the mitochondrial DNA displacement-loop (D-loop) region have been reported to be associated with cancer risk and disease outcome in several types of cancer. In this study, we investigated whether the SNPs in mitochondrial D-loop were associated with the outcome of malignant fibrous histiocytoma (MFH). Experimental design: The D-loop region of mtDNA was sequenced for 80 MFH patients. The 3 years survival curve were calculated with the Kaplan-Meier method and compared by the log-rank test at each SNP site, a multivariate survival analysis was also performed with the Cox proportional hazards method. Results: The SNP sites of nucleotides 152T/C, 16,390G/A, 16,290C/T, 16,304T/C and the AC deletion at sites 523 and 524 were identified for prediction of post-operational survival by the log-rank test. In an overall multivariate analysis, the 16,290 and 16,390 alleles were identified as independent predictors of MFH outcome. The length of survival for patients with the rare allele 16,390A genotype was significantly shorter than that for patients with the frequent allele 16,390Gat the site 16,390. The same was seen for the rare allele 16,290T genotype when compared with matched allele 16,290C at the site 16,290 in MFH patients. Conclusions: These results suggested that SNPs in the D-loop are independent prognostic markers for patients with MFH. The analysis of genetic polymorphisms in the D-loop can help identify patient subgroups at higher risk of a poor disease outcome.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2016]版:
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 遗传学
JCR分区:
出版当年[2016]版:
Q4 GENETICS & HEREDITY
最新[2024]版:
Q4 GENETICS & HEREDITY

影响因子: 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Osteology,The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China [*1]Department of Osteology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, P.R. China.
通讯作者:
通讯机构: [1]Department of Osteology,The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China [*1]Department of Osteology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号